The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Bennett, Sara ^a   Paina, Ligia ^a   Ssengooba, Freddie ^b   Waswa, Douglas ^c   M'Imunya, James M ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^c University of Nairobi ^*

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

HIV AIDS; Policy influence; Research capacity

Indexed keywords

DEVELOPING COUNTRY; ECONOMICS; EDUCATION; HIV INFECTIONS; HUMAN; KENYA; MEDICAL RESEARCH; POLICY; PROGRAM DEVELOPMENT; QUESTIONNAIRE; UGANDA; UNITED STATES;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; KENYA; PROGRAM DEVELOPMENT; PUBLIC POLICY; QUESTIONNAIRES; TRAINING SUPPORT; UGANDA; UNITED STATES;

EID: 84882296089     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-770     Document Type: Article

References (46)

1. Strengthening capacity for health research in Africa. Whitworth JA, et al. Lancet 2008 372 9649 1590 1593 10.1016/S0140-6736(08)61660-8 18984193
2. Research capacity building in Africa: networks, institutions and local ownership. Marjanovic S, et al. J Int Dev 2012 doi:10.1002/jid.2870
3. DFID, DFID Research Strategy: 2008-2013 DFID: London 2008
4. Research capacity strengthening in the South. Nchinda TC, Soc Sci Med 2002 54 11 1699 1711 10.1016/S0277-9536(01)00338-0 12113452
5. Research capacity strengthening: donor approaches to improving and assessing its impact in low- and middle-income countries. Gadsby EW, Int J Health Plann Manage 2011 26 1 89 106 10.1002/hpm.1031 20422620
6. Impact of health research capacity strengthening in low- and middle-income countries: the case of WHO/TDR programmes. Minja H, et al. PLoS Negl Trop Dis 2011 5 10 1351 doi:10.1371/journal.pntd.0001351 10.1371/journal.pntd.0001351 22022630
7. Global health: the Fogarty International Center, National Institutes of Health: vision and Mission, Programs and Accomplishments. Bremen J, et al. Infect Dis Clin North Am 2011 25 3 311 336 doi:10.1016/j.idc.2011.06.003 21628047
8. Investing to meet the scientific challenges of HIV/AIDS. Fauci AS, Folkers GK, Health Aff (Millwood) 2009 28 6 1629 1641 10.1377/hlthaff.28.6.1629
9. Knowledge transfer and exchange: review and synthesis of the literature. Mitton C, et al. Milbank Q 2007 85 4 729 768 10.1111/j.1468-0009.2007.00506.x 18070335
10. Contribution mapping: a method for mapping the contribution of research to enhance its impact. Kok MO, Schuit AJ, Health Res Policy Syst 2012 10 21 10.1186/1478-4505-10-21 22748169
11. Payback arising from research funding: evaluation of the Arthritis Research Campaign. Wooding S, et al. Rheumatology (Oxford) 2005 44 9 1145 1156 10.1093/rheumatology/keh708
12. Research capacity building in international health: definitions, evaluations and strategies for success. Trostle J, Soc Sci Med 1992 35 11 1321 1324 10.1016/0277-9536(92)90035-O 1462171
13. Gerring J, Case study research: Principles and practice Cambridge: Cambridge University Press 2007
14. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). Musoke P, et al. AIDS 1999 13 4 479 486 10.1097/00002030-199903110-00006 10197376
15. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Guay LA, et al. Lancet 1999 354 9181 795 802 10.1016/S0140-6736(99)80008-7 10485720
16. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Jackson JB, et al. Lancet 2003 362 9387 859 868 10.1016/S0140-6736(03)14341-3 13678973
17. HIVNET nevirapine trials. Hudson CP, Moodley J, Lancet 1999 354 9192 1817 1818 10577662
18. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Gray RH, et al. Lancet 2007 369 9562 657 666 10.1016/S0140-6736(07)60313-4 17321311
19. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Adatu F, et al. Int J Tuberc Lung Dis 2003 7 9 Suppl 1 63 S71 12971656
20. Task shifting for tuberculosis control: a qualitative study of community-based directly observed therapy in urban Uganda. Mafigiri DK, McGrath JW, Whalen CC, Glob Public Health 2012 7 3 270 84 doi:10.1080/17441692.2011. 552067 10.1080/17441692.2011.552067 21360381
21. Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda. Katamba A, Laticevschi D, Rieder HL, Int J Tuberc Lung Dis 2007 11 6 659 664 17519098
22. Consumption of alcoholic beverages among pregnant urban Ugandan women. Namagembe I, et al. Matern Child Health J 2010 14 4 492 500 10.1007/s10995-009- 0500-3 19629663
23. Acute HIV infection among Kenyan infants. Richardson BA, et al. Clin Infect Dis 2008 46 2 289 295 10.1086/524748 18171265
24. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. Rousseau CM, et al. J Infect Dis 2004 190 10 1880 1888 10.1086/425076 15499546
25. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. Nduati R, et al. JAMA 2000 283 9 1167 1174 10.1001/jama.283.9.1167 10703779
26. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Nduati R, et al. Lancet 2001 357 9269 1651 1655 10.1016/S0140-6736(00)04820-0 11425369
27. HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. Otieno PA, et al. J Infect Dis 2007 195 2 220 229 10.1086/510245 17191167
28. Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. Kiarie JN, et al. J Acquir Immune Defic Syndr 2004 35 1 75 81 10.1097/00126334-200401010-00011 14707796
29. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. Mbori-Ngacha D, et al. JAMA 2001 286 19 2413 2420 10.1001/jama.286.19.2413 11712936
30. Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Cherutich P, et al. Bull World Health Organ 2008 86 2 155 160 10.2471/BLT.07.040402 18297171
31. Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. Inwani I, et al. J Acquir Immune Defic Syndr 2009 50 5 492 498 10.1097/QAI.0b013e318198a8a4 19225401
32. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. Lingappa JR, et al. PLoS One 2009 4 4 5272 10.1371/journal.pone.0005272 19404392
33. Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. Lingappa JR, et al. PLoS One 2008 3 1 1411 10.1371/journal.pone.0001411 18183292
34. Sexually transmitted infections among HIV-1-discordant couples. Guthrie BL, et al. PLoS One 2009 4 12 8276 10.1371/journal.pone.0008276 20011596
35. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Richardson BA, et al. Sex Transm Dis 2001 28 7 394 400 10.1097/00007435-200107000-00006 11460023
36. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. Kaul R, et al. JAMA 2004 291 21 2555 2562 10.1001/jama.291.21.2555 15173146
37. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. Kaul R, et al. J Infect Dis 2007 196 11 1692 1697 10.1086/522006 18008255
38. Response of a sexually transmitted infection epidemic to a treatment and prevention programme in Nairobi, Kenya. Moses S, et al. Sex Transm Infect 2002 78 Suppl 1 114 i120 12083429
39. Quality of sexually transmitted disease case management in Nairobi, Kenya: a comparison among different types of healthcare facilities. Voeten HA, et al. Sex Transm Dis 2001 28 11 633 642 10.1097/00007435-200111000-00005 11677385
40. Epistemic Communities and International-Policy Coordination-Introduction. Haas PM, Int Organ 1992 46 1 1 35 10.1017/S0020818300001442
41. Health policy-makers perception of their use of evidence: a systematic review. Innvaer S, et al. J Health Serv Res Pol 2002 7 4 239 244 10.1258/135581902320432778
42. National policy-makers speak out: are researchers giving them what they need? Hyder AA, et al. Health Policy Plan 2011 26 1 73 82 10.1093/heapol/czq020 20547652
43. Using knowledge brokering to promote evidence-based policy-making: the need for support structures. van Kammen J, de Savigny D, Sewankambo N, Bull World Health Organ 2006 84 8 608 612 10.2471/BLT.05.028308 16917647
44. Describing the impact of health research: a research impact framework. Kuruvilla S, et al. BMC Health Serv Res 2006 6 134 10.1186/1472-6963-6-134 17049092
45. Ortiz A, Taylor P, Learning Purposefully in Capacity Development. Why, what and when to measure? Paris: UNESCO 2009 1 49
46. What is the societal impact of resaerch and how can it be assessed? A literature survey. Bornmann L, J Am Soc Inf Sci Technol 2013 64 2 217 233 10.1002/asi.22803